Yonsei Med J.  2023 Apr;64(4):251-258. 10.3349/ymj.2022.0499.

Effective Timing of Introducing an Inpatient Smoking Cessation Program to Cancer Patients

• Choe YR
• Choi JW
• Jeong JR
• Doh HM
• Kim ML
• Nam MS
• Kho HJ
• Park HY
• Ahn HR
• Kweon SS
• Kim YI
• Oh IJ

• KMID: 2541127
• DOI: http://doi.org/10.3349/ymj.2022.0499

Abstract

Purpose
We aimed to identify factors influencing smoking cessation success among cancer patients registered in an inpatient smoking cessation program at a single cancer center.
Materials and Methods
The electronic medical records of enrolled patients with solid cancer were retrospectively reviewed. We evaluated factors associated with 6-month smoking cessation.
Results
A total of 458 patients with cancer were included in this study. Their mean age was 62.9±10.3 years, and 56.3% of the participants had lung cancer. 193 (42.1%) had not yet begun their main treatment. The mean number of counseling sessions for the participants was 8.4±3.5, and 46 (10.0%) patients were prescribed smoking cessation medications. The 6-month smoking cessation success rate was 48.0%. Multivariate analysis showed that younger age (<65 years), cohabited status, early stage, and the number of counseling sessions were statistically significant factors affecting 6-month smoking cessation success (p<0.05). Initiation of a cessation program before cancer treatment was significantly associated with cessation success (odds ratio, 1.66; 95% confidence interval, 1.02–2.70; p=0.040).
Conclusion
Smoking cessation intervention must be considered when establishing a treatment plan immediately after a cancer diagnosis among smokers.

Keyword

Cancer; inpatients; lung cancer; smoking cessation